CLL patients with XPO1 E571 mutations had poor prognosis and harboured altered IFNγ, granzyme B and CD28 expression, which may contribute to the overall immune dysfunction seen in CLL patients [40, 43]. The gene discussed is IFNG; the disease is B-cell chronic lymphocytic leukemia.